Examine the data and tweets to deduce if the closing price of $bmy will boost or lower at 2017-05-26. Kindly confirm either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-05-12,0.3,0.6,-0.4,-0.2,-0.2,0.2,0.5,0.1,-0.8,-1.3,-1.5
2017-05-15,-0.1,0.2,-0.5,0.1,0.1,0.1,0.2,0.2,-0.7,-1.3,-1.6
2017-05-16,1.1,1.6,-0.3,-1.3,-1.3,1.0,1.2,1.5,0.7,0.1,-0.3
2017-05-17,-0.0,0.4,-1.3,0.0,0.0,0.7,1.0,1.6,0.8,0.1,-0.3
2017-05-18,0.8,1.3,-0.9,-1.2,-1.2,1.4,2.0,2.5,2.0,1.4,1.0
2017-05-19,-0.4,0.5,-0.4,0.4,0.4,0.6,1.3,1.8,1.6,1.0,0.5
2017-05-22,-0.1,0.4,-0.4,0.1,0.1,0.1,1.0,1.4,1.5,0.9,0.4
2017-05-23,-0.1,0.4,-0.1,0.2,0.2,-0.2,0.6,1.0,1.3,0.8,0.3
2017-05-24,1.2,1.2,-0.7,-0.7,-0.7,0.3,1.1,1.5,2.1,1.6,1.1
2017-05-25,-0.9,0.3,-1.3,1.1,1.1,-0.5,-0.1,0.4,0.9,0.6,0.1

2017-05-12: is now a good time to buy $jpm $snap $bac $ibm $mpc  $teva $bmy $abbv $hot $v $mdt $axp $dow #ces2018 #ai|five prime therapeutics at an attractive entry level $bmy $fprx  #investing #stocks |five prim
2017-05-13: $pfe hints a $bmy deal is on the table |$vdrm $tsla $kerx $pfe $mrk $adxs $bmy $bac $gs $jpm $amd $dcth $ftr $foxa $csco $himx $eric $amat $qcom $asna¡­ |$amgn 34% profit margins are way above industr
2017-05-14: somewhat positive media coverage very likely to affect bristol-myers squibb $bmy stock price |$apri +126%. see track record &amp; subscribe    $jah $clr $dis $mo $bmy $pot|rt AT_USER trump-care asks a
2017-05-15: rt AT_USER #google #dcvax-l overall survival outpacing chemo everyday.$kite $juno $fgen $exel $bmy #opdivo $mrk #keytruda #asco17 comb¡­|rt AT_USER AT_USER dr pat AT_USER $nwbo dcvax combo $bmy #opdiv
2017-05-16: rt AT_USER on the fly: top stock stories for tuesday $hd $pfe $bmy $agn $twtr $sina $wb $etsy $dks $rad $wba |rt AT_USER $nwbo $bmy $mrk high side effects pd1 cis take the brakes off the immune system
2017-05-17: AT_USER $bmy data looks strong but stock down after hours|bristol-myers squibb after 1q17: portfolio prospects  $bmy $jnj $pfe $lly|rt AT_USER ditto for the scchn cohort in that only dcr is provided (
2017-05-18: rt AT_USER incyte teams up with dow's merck to trounce roche in cancer $incy $mrk $bmy $rhhby $nlnk |rt AT_USER $nwbo $bmy $mrk high side effects pd1 cis take the brakes off the immune system. but low
2017-05-19: is now a good time to buy $jpm $snap $bac $ibm $mpc  $teva $bmy $abbv $hot $v $mdt $axp $dow #ces2018 #ai|is now a good time to buy $jpm $snap $bac $ibm $mpc  $teva $bmy $abbv $hot $v $mdt $axp $dow #
2017-05-20: rt AT_USER and cheap af. hempton gave me $5 though! $vrx $agn myl $cmg $brk $iep $hlf $twtr $aapl $snap $bmy $ko $pep $crm $tst $shak¡­|and cheap af. hempton gave me $5 though! $vrx $agn myl $cmg $brk
2017-05-21: rt AT_USER heads up! a new report on anti-pd(l)1 combination studies will be published by AT_USER before #asco17 $mrk $bmy $rhhby¡­|rt AT_USER and cheap af. hempton gave me $5 though! $vrx $agn myl $c
2017-05-22: rt AT_USER this could be in the top 50 disruptive technologies this year.  #dcvax $nwbo $juno $kite $blue $agio $celg $gild $bmy $nvs¡­|$bmy is in three inside up winning 63.64% in the past. |valeant 
2017-05-23: rt AT_USER AT_USER watch what happens after p3 topline $nwbo buyout $cpxx style $bmy $mrk both collaborated with $nwbo $amgn¡­|somewhat positive press coverage very likely to affect bristol-myers squi
2017-05-24: rt AT_USER dcvax-l the next disruptive technology.  it will play well with others also.  $nwbo $bmy $mrk $kite $juno $exel $nvs $gild¡­|rt AT_USER dcvax-l the next disruptive technology.  it will play
2017-05-25: rt AT_USER #dcvax-l 4 #gbm #dcvaxdirect 13 cancer indications.  robust pipeline. #google $nwbo #disrupt #cancer $kite $juno $bmy $mrk¡­|fda drug approvals rebound from last year, up... $lly $bmy $pfe 
Answer:
Examine the data and tweets to deduce if the closing price of $bmy will boost or lower at 2017-05-26. Kindly confirm either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-05-12,0.3,0.6,-0.4,-0.2,-0.2,0.2,0.5,0.1,-0.8,-1.3,-1.5
2017-05-15,-0.1,0.2,-0.5,0.1,0.1,0.1,0.2,0.2,-0.7,-1.3,-1.6
2017-05-16,1.1,1.6,-0.3,-1.3,-1.3,1.0,1.2,1.5,0.7,0.1,-0.3
2017-05-17,-0.0,0.4,-1.3,0.0,0.0,0.7,1.0,1.6,0.8,0.1,-0.3
2017-05-18,0.8,1.3,-0.9,-1.2,-1.2,1.4,2.0,2.5,2.0,1.4,1.0
2017-05-19,-0.4,0.5,-0.4,0.4,0.4,0.6,1.3,1.8,1.6,1.0,0.5
2017-05-22,-0.1,0.4,-0.4,0.1,0.1,0.1,1.0,1.4,1.5,0.9,0.4
2017-05-23,-0.1,0.4,-0.1,0.2,0.2,-0.2,0.6,1.0,1.3,0.8,0.3
2017-05-24,1.2,1.2,-0.7,-0.7,-0.7,0.3,1.1,1.5,2.1,1.6,1.1
2017-05-25,-0.9,0.3,-1.3,1.1,1.1,-0.5,-0.1,0.4,0.9,0.6,0.1

2017-05-12: is now a good time to buy $jpm $snap $bac $ibm $mpc  $teva $bmy $abbv $hot $v $mdt $axp $dow #ces2018 #ai|five prime therapeutics at an attractive entry level $bmy $fprx  #investing #stocks |five prim
2017-05-13: $pfe hints a $bmy deal is on the table |$vdrm $tsla $kerx $pfe $mrk $adxs $bmy $bac $gs $jpm $amd $dcth $ftr $foxa $csco $himx $eric $amat $qcom $asna¡­ |$amgn 34% profit margins are way above industr
2017-05-14: somewhat positive media coverage very likely to affect bristol-myers squibb $bmy stock price |$apri +126%. see track record &amp; subscribe    $jah $clr $dis $mo $bmy $pot|rt AT_USER trump-care asks a
2017-05-15: rt AT_USER #google #dcvax-l overall survival outpacing chemo everyday.$kite $juno $fgen $exel $bmy #opdivo $mrk #keytruda #asco17 comb¡­|rt AT_USER AT_USER dr pat AT_USER $nwbo dcvax combo $bmy #opdiv
2017-05-16: rt AT_USER on the fly: top stock stories for tuesday $hd $pfe $bmy $agn $twtr $sina $wb $etsy $dks $rad $wba |rt AT_USER $nwbo $bmy $mrk high side effects pd1 cis take the brakes off the immune system
2017-05-17: AT_USER $bmy data looks strong but stock down after hours|bristol-myers squibb after 1q17: portfolio prospects  $bmy $jnj $pfe $lly|rt AT_USER ditto for the scchn cohort in that only dcr is provided (
2017-05-18: rt AT_USER incyte teams up with dow's merck to trounce roche in cancer $incy $mrk $bmy $rhhby $nlnk |rt AT_USER $nwbo $bmy $mrk high side effects pd1 cis take the brakes off the immune system. but low
2017-05-19: is now a good time to buy $jpm $snap $bac $ibm $mpc  $teva $bmy $abbv $hot $v $mdt $axp $dow #ces2018 #ai|is now a good time to buy $jpm $snap $bac $ibm $mpc  $teva $bmy $abbv $hot $v $mdt $axp $dow #
2017-05-20: rt AT_USER and cheap af. hempton gave me $5 though! $vrx $agn myl $cmg $brk $iep $hlf $twtr $aapl $snap $bmy $ko $pep $crm $tst $shak¡­|and cheap af. hempton gave me $5 though! $vrx $agn myl $cmg $brk
2017-05-21: rt AT_USER heads up! a new report on anti-pd(l)1 combination studies will be published by AT_USER before #asco17 $mrk $bmy $rhhby¡­|rt AT_USER and cheap af. hempton gave me $5 though! $vrx $agn myl $c
2017-05-22: rt AT_USER this could be in the top 50 disruptive technologies this year.  #dcvax $nwbo $juno $kite $blue $agio $celg $gild $bmy $nvs¡­|$bmy is in three inside up winning 63.64% in the past. |valeant 
2017-05-23: rt AT_USER AT_USER watch what happens after p3 topline $nwbo buyout $cpxx style $bmy $mrk both collaborated with $nwbo $amgn¡­|somewhat positive press coverage very likely to affect bristol-myers squi
2017-05-24: rt AT_USER dcvax-l the next disruptive technology.  it will play well with others also.  $nwbo $bmy $mrk $kite $juno $exel $nvs $gild¡­|rt AT_USER dcvax-l the next disruptive technology.  it will play
2017-05-25: rt AT_USER #dcvax-l 4 #gbm #dcvaxdirect 13 cancer indications.  robust pipeline. #google $nwbo #disrupt #cancer $kite $juno $bmy $mrk¡­|fda drug approvals rebound from last year, up... $lly $bmy $pfe 
Answer:+Fall